IRIS
CASCINU, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.063
NA - Nord America 1.017
AS - Asia 106
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 3
AF - Africa 1
Totale 2.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.013
SE - Svezia 750
IT - Italia 136
FI - Finlandia 80
CN - Cina 50
DE - Germania 31
IE - Irlanda 25
IN - India 18
IR - Iran 11
ES - Italia 9
EU - Europa 9
JP - Giappone 9
RU - Federazione Russa 9
FR - Francia 8
BR - Brasile 7
SG - Singapore 7
GB - Regno Unito 5
AR - Argentina 4
CA - Canada 4
AU - Australia 3
PH - Filippine 3
VN - Vietnam 3
A1 - Anonimo 2
NL - Olanda 2
PT - Portogallo 2
AL - Albania 1
BD - Bangladesh 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HK - Hong Kong 1
IL - Israele 1
MK - Macedonia 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 2.212
Salva come PNG Salva come JPEG
Città #
Lawrence 315
Princeton 314
New York 112
Helsinki 80
Ashburn 62
Shanghai 46
Dublin 25
Milan 22
Los Angeles 15
Rome 10
Washington 8
Seattle 6
Tokyo 5
Borås 4
Martinez 4
Oria 4
Pescara 4
Pune 4
Verona 4
Hanoi 3
Hanover 3
Hyderabad 3
London 3
Mumbai 3
Beijing 2
Brasília 2
Brighton 2
Castelfranco Emilia 2
Cerreto Guidi 2
Chiyoda-ku 2
Florence 2
Foggia 2
Genoa 2
Harwich 2
Kish 2
Lisbon 2
Ludhiana 2
Lyon 2
Manila 2
Messina 2
Modena 2
Monza 2
Mountain View 2
Paris 2
Redwood City 2
Rimini 2
Rockville 2
Rubano 2
San Fernando de Henares 2
Sesto San Giovanni 2
St Petersburg 2
Toronto 2
Trieste 2
Turin 2
Visakhapatnam 2
Yekaterinburg 2
Aalter 1
Aioicho 1
Alba 1
Amsterdam 1
Andover 1
Ann Arbor 1
Athis-mons 1
Aversa 1
Berlin 1
Bhubaneswar 1
Boardman 1
Bologna 1
Bom Despacho 1
Brisbane 1
Buccinasco 1
Chivasso 1
Council Bluffs 1
Dallas 1
Dalmine 1
Darjeeling 1
Dijon 1
Geislingen an der Steige 1
Gliwice 1
Goala Bazar 1
Henderson 1
Hung Hom 1
Jalandhar 1
Karlsruhe 1
Kashan 1
Kolkata 1
Leawood 1
Marche 1
Melbourne 1
Meskiana 1
Monteforte Irpino 1
Moscow 1
Nizhniy Novgorod 1
Omsk 1
Pomezia 1
Pontirolo Nuovo 1
Redmond 1
Riegelsberg 1
Riyadh 1
San Francisco 1
Totale 1.167
Salva come PNG Salva come JPEG
Nome #
null 37
Early integration of palliative care in oncology practice: Results of the Italian Association of Medical Oncology (AIOM) survey 26
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients 24
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial 23
Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors 23
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas 17
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 17
null 16
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 16
The role of anti-angiogenics in pre-treated metastatic BRAF-mutant colorectal cancer: A pooled analysis 16
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes 16
Metabolism and immune modulation in patients with solid tumors: Systematic review of preclinical and clinical evidence 16
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study 15
Dabrafenib-trametinib combination in 'field-practice': An Italian experience 15
BRAF-mutated colorectal cancer: Clinical and molecular insights 15
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 15
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC) 15
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX 15
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 15
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 15
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time? 15
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial 15
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 14
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 14
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 14
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 14
Atezolizumab and bevacizumab in advanced HCC: ready for prime time? 14
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 14
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 14
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 14
Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses 13
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? 13
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 13
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 13
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials 13
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study 13
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 13
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study (Targeted Oncology, (2020), 15, 1, (115-126), 10.1007/s11523-020-00698-x) 13
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 13
Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic 12
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors 12
To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer 12
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale 12
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 12
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients 12
5-Fluorouracil pharmacogenomics: still rocking after all these years? 12
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 11
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 11
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 11
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 11
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 11
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 11
Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer 11
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study 11
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients 11
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) 11
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going 11
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 11
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 11
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 11
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 11
Anal cancer: from an orphan disease to a curable malignancy? 11
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 11
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives 11
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis 11
Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practice 11
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 11
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 11
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 11
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 11
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 11
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 11
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 10
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable? 10
Adjuvant chemotherapy in colon cancer: can we improve quality of care? 10
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer 10
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus 10
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 10
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 10
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials 10
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 10
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients 10
Gastric cancer: Translating novels concepts into clinical practice 10
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW 10
Second-line treatments: Moving towards an opportunity to improve survival in advanced gastric cancer? 10
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 10
The Italian Rare Pancreatic Exocrine Cancer Initiative 10
Cholangiocarcinoma: new perspectives for new horizons 10
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 10
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis 10
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 9
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 9
Compliance with breast and cervical cancer screening programs in women: results from a population-based study 9
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy 9
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 9
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients 9
GD2 expression in breast cancer 9
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy 9
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II tria 9
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor 9
Totale 1.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 5 0 131 41 91 0 0 1 0
2021/2022230 0 1 0 99 7 7 23 44 19 7 6 17
2022/20231.527 738 284 86 8 13 201 41 73 59 6 10 8
2023/2024555 23 38 88 84 43 148 11 61 9 28 22 0
Totale 2.583